|
|
| | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid Basic information |
| Product Name: | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid | | Synonyms: | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid;3-[(1E)-2-[2-Chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]benzoic acid;Benzoic acid, 3-[(1E)-2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]-;3-[(1E)-2-(2-chloro-4-{[3-(2,6-dichlorophenyl)-5-(propan-2-yl)-1,2-oxazol-4-yl]methoxy}phenyl)ethenyl]benzoic acid | | CAS: | 1089660-72-9 | | MF: | C28H22Cl3NO4 | | MW: | 542.84 | | EINECS: | | | Product Categories: | | | Mol File: | 1089660-72-9.mol |  |
| | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid Chemical Properties |
| Boiling point | 702.1±60.0 °C(Predicted) | | density | 1.367 | | pka | 4.17±0.10(Predicted) |
| | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid Usage And Synthesis |
| Uses | (E)-GW 4064 is a FXR agonist[1]. | | Definition | ChEBI: GW 4064 is a stilbenoid. | | References | [1] Helen B. Hartman, et al. FXR Agonists for the Treatment of Malignancies. Patent US20080299118. |
| | (E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid Preparation Products And Raw materials |
|